In agreement with the in vitro results, in vivo subcutaneous tumor model experiments showed that TRIM47 overexpressing cells formed smaller tumors compared with vector-transformed cells in Olaparib treatment group, but there was no significant change in the vehicle group (Fig. 6C). The gene discussed is TRIM47; the disease is neoplasm.